Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB
Treatment and conditionWhere it standsTrials
Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB for laryngeal diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB for lung diseases, interstitialPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1